With DARAPRIM Direct, your patients will have a dedicated DARAPRIM Direct Case Manager to assist them through every step.
To learn how to prescribe DARAPRIM, click below.
The DARAPRIM Direct Program was created to help patients obtain quick and affordable access to DARAPRIM. From the moment you’ve prescribed DARAPRIM, dedicated Case Managers can help educate and support your patients through every step.
The DARAPRIM Direct Program helps ensure that you have one less concern when it comes to getting your patients started on their medication. A DARAPRIM Direct Case Manager will work with your patient to understand their insurance coverage, financial needs and the financial assistance programs that they may be eligible for.1
If you are uninsured and meet eligibility criteria, you can get DARAPRIM for no cost
If you have commercial or private insurance, you may pay as little as $10 out-of-pocket for your prescription*
If you are covered by Medicare or Medicaid, our team can refer you to independent copay foundations and state programs that may be able to help you pay for your disease treatment
1Financial assistance programs are subject to terms and conditions and patient eligibility requirements. Restrictions, including where prohibited by law, may apply. Offers are subject to change or discontinuance without notice. Financial assistance programs are not insurance nor are they intended to be a substitute for insurance.
*Limitations apply. Maximum benefit of up to $5,000 per month, with a $15,000 annual cap per calendar year. See full Copay Terms and Conditions below.
DARAPRIM® (pyrimethamine) is indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide.
IMPORTANT SAFETY INFORMATION
DARAPRIM is contraindicated in patients with known hypersensitivity to pyrimethamine or to any component of the formulation and in patients with documented megaloblastic anemia due to folate deficiency.
Potential for folate deficiency: Dosage required for toxoplasmosis treatment approaches the toxic level. If signs of folate deficiency develop, reduce the dosage or discontinue the drug according to patient response. Administer folinic acid (leucovorin) at 5-15 mg per day until normal hematopoiesis is restored.
Carcinogenic potential: Data indicates that pyrimethamine may be carcinogenic.
Pregnancy Category C:
Pyrimethamine is excreted in human milk. Because of the potential for serious adverse reactions in nursing infants from pyrimethamine, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
Keep out of the reach of infants and children: Deaths in pediatric patients have been reported after accidental ingestion.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. To report SUSPECTED ADVERSE REACTIONS contact Vyera Pharmaceuticals, LLC at 1-877-258-2033.